Home8BT • FRA
add
Briacell Therapeutics Corp
Previous close
€0.34
Day range
€0.30 - €0.33
Year range
€0.30 - €4.02
Market cap
24.75M CAD
Avg Volume
334.00
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Oct 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.15M | -39.40% |
Net income | -5.80M | -196.68% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -5.13M | 39.69% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Oct 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.79M | -57.55% |
Total assets | 10.41M | -44.07% |
Total liabilities | 6.70M | -58.38% |
Total equity | 3.71M | — |
Shares outstanding | 44.20M | — |
Price to book | 3.11 | — |
Return on assets | -158.19% | — |
Return on capital | -2,506.04% | — |
Cash Flow
Net change in cash
| (USD) | Oct 2024info | Y/Y change |
|---|---|---|
Net income | -5.80M | -196.68% |
Cash from operations | -6.96M | 8.55% |
Cash from investing | -75.00K | — |
Cash from financing | 11.96M | — |
Net change in cash | 4.93M | 164.83% |
Free cash flow | -5.03M | -9.53% |
About
Founded
2006
Headquarters
Website
Employees
17
